Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07076238 · ClinicalTrials.gov registry record
Biomarkers of Phage Treatment Response in NTM and Other Infections
A clinical trial of Nontuberculous Mycobacterial Lung Disease, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07076238 is a study of Nontuberculous Mycobacterial Lung Disease that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07076238, a study of Nontuberculous Mycobacterial Lung Disease, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to identify biomarkers associated with response to phage therapy for refractory bacterial infections. This includes mycobacteriophage treatment for patients with nontuberculous mycobacterial infections. Blood and airway samples will be obtained from follow up visits of patients with refractory bacterial infections that are considered for phage therapy. Samples will be compared between those that receive phage therapy and those that did not. Biomarkers will include changes in the airway microbiome, transcriptome, inflammatory cytokines, and development of neutralizing antibody against phages. The primary endpoint is to identify biomarkers associated with clinical and/or radiographic improvement and/or culture improvement which includes clearing of cultures or decrease in qualitative or resolution of signs and symptoms of infection after at least 6-8 weeks of bacteriophage therapy.
Conditions Studied
Interventions
- BIOLOGICAL Bacteriophage Treatment
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2032-06-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07076238
The ClinicalTrials.gov registry entry for NCT07076238 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nontuberculous Mycobacterial Lung Disease appearing as the primary indexed condition, and to 1 intervention - of which Bacteriophage Treatment is the first listed.
NCT07076238 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07076238 about?
NCT07076238 is a clinical study titled "Biomarkers of Phage Treatment Response in NTM and Other Infections". This study aims to identify biomarkers associated with response to phage therapy for refractory bacterial infections. This includes mycobacteriophage treatment for patients with nontuberculous mycobacterial infections. Blood and airway samples will be obtained from follow up visits of patients with ...
What is the current status of trial NCT07076238?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-06-25. Estimated completion is 2032-06-25.
What conditions does trial NCT07076238 study?
This clinical trial studies the following conditions: Nontuberculous Mycobacterial Lung Disease.
What interventions are being tested in trial NCT07076238?
The interventions under investigation include: Bacteriophage Treatment (BIOLOGICAL).
Who is sponsoring clinical trial NCT07076238?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07076238 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nontuberculous Mycobacterial Lung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.